No evidence of benefit for chloroquine and hydroxychloroquine in COVID-19 patients, study finds
Friday, 22 May 2020 () A new study finds that the use of chloroquine or hydroxychloroquine is linked to increased rates of mortality and heart arrhythmias among hospital patients with COVID-19. The authors suggest that these drug regimens should not be used to treat COVID-19 outside of clinical trials and urgent confirmation from randomised clinical trials is needed.
According to UPI, chloroquine and hydroxychloroquine has no clinical benefit for people with COVID-19.
A study published in The Lancet on Friday says that the drugs might actually cause serious heart-related side effects.
The study of 15,000 patients found increased rate of heart-related side...